Clinical Trial Update: Lymphocyte Therapy in Treating Patients With Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update from the National Cancer Institute on lymphocyte therapy for kidney cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Drugs mentioned

• Adoptive lymphocyte therapy (adoptive lymphocyte therapy)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Kidney Cancer | Phase 2 | Status: UNKNOWN